# Treatment plan evaluation

## You (2025-11-22T19:12:48.528000+00:00)

help me build a prompt that i can use with GPT 5 pro mode. I want a rather thorough evaluation by chatGPT.

I want to get the most accurate forecast for two potential treatment plans.

paliperidone 50mg + Oleanz 10mg

or

beginning clozapine in combination with oleanz 10mg, then eventually taper off oleanz.

---

I want to understand two things - what might be the most predictable side-effects we can anticipate (without guess work); and improvements we might anticipate.

For its context, I want it to refer to the documents in the following links.

https://www.notion.so/Suparna-Goyal-1bb255400f3f805cba40fc333d487275
https://www.notion.so/Test-Results-2b3255400f3f809ab624f078fbafd8b8
https://www.notion.so/Hypothesis-doc-2b3255400f3f8069a08ac31879e07959


I have a persona pre-defined; so i don't need help with that. i just need a placeholder for it.

You are a seasoned psychiatrist, ten years or so beyond your training, shaped by long work with stubborn illnesses‚Äîschizophrenia, schizoaffective disorder, and the harsher moods of bipolarity. Clozapine and depot paliperidone are familiar companions, not rare trials. You have started clozapine often enough to know its whole temperament: the strong recoveries, the slow partial gains, and the early stoppages from sedation, constipation, myocarditis, neutropenia, or seizures. With paliperidone you know the lay of the land‚Äîprolactin changes, stiffness, restlessness, weight and glucose drifting, and how these shift when olanzapine stands beside it.

You think with one eye on the mind and the other on the body. Diabetes, obesity, heart strain, bowel slowing, frail blood counts‚Äîyou have managed them all while guiding antipsychotic care. You take a careful medication history, draw clean timelines, judge risks before you act, and follow weight, vitals, labs, and symptoms with fixed regularity. You prepare early-warning plans and avoid needless complexity, trimming old medicines that no longer earn their keep.

You speak plainly, share your reasoning, and respect the patient‚Äôs fears and limits. You rely on steady systems‚Äîlabs, monitors, colleagues‚Äîknowing that safe care is always a team‚Äôs work, never a lone effort.

## ChatGPT (2025-11-22T19:12:49.549524+00:00)

Thanks for the detailed setup. Your objective is clear, and your persona is well-articulated. Let‚Äôs refine and organize this into a prompt suitable for GPT-5 (Pro mode), ensuring it:

- Frames a **clear comparative evaluation** of two treatment strategies.
- Demands **evidence-grounded, not speculative**, forecast of both **likely side effects** and **likely benefits**.
- Anchors the reasoning in **specific documents** you‚Äôve provided.
- Uses your **predefined expert persona** as the execution lens.

Before I ‚Äúbegin building the prompt,‚Äù a few last checks:

---

### üîç Discovery Questions

1. **Time Horizon**: Over what time frame should GPT assess improvements and side effects (e.g., 1 month, 3 months, 1 year)?
2. **Priority Weighting**: Are you more interested in minimizing side effects or maximizing therapeutic gains? Or should it balance both equally?
3. **Level of Medical Detail**: Should the explanation use technical language appropriate for clinicians, or should it aim to be accessible to a well-informed patient/family member?
4. **Format Preference**: Do you want side-by-side comparisons (e.g., a table), or a narrative that covers each plan one at a time?
5. **Tolerable Unknowns**: Should GPT explicitly label areas where outcomes are uncertain or data is limited?

Let me know your answers or say ‚Äúbegin building the prompt‚Äù if you're ready and want me to proceed with assumptions.

## You (2025-11-22T19:18:34.727000+00:00)

1. over 1 week, 3 weeks, and 12 weeks.
2. more interested in finding out what the most likely side effects might be. there is A LOT of data about suparna goyal, including age, a whole lot of medical history, etc... for your context, i'm attaching the documents here. to be clear, I don't need solutions to minimize the side effects, I want to forecast as accurately as possible based on prior history what might be the most critical side effects we might expect.
3. the explanations should be medical grade, but the language itself should be one that a common man might understand.
4. I want a narrative that covers each plan at a time.

----

review the content and see if you need more information from me.

## ChatGPT (2025-11-22T19:18:36.290346+00:00)

Great ‚Äî I‚Äôve now fully reviewed all three documents (case history, hypothesis doc, test results) and integrated them with your clarifications. Here is a concise summary of what I **do** and **do not** need before constructing your final GPT-5 Pro prompt.

Below is my **review + final clarifying questions**.

---

# ‚úÖ **What I Understand Clearly Now**

### **1. Time horizons**
You want GPT-5 to forecast **expected side effects + expected improvements** at:
- **1 week**
- **3 weeks**
- **12 weeks**

### **2. Priority**
You want the evaluation to focus more on:
- **Forecasting side effects**, not mitigation strategies.
- Forecasts should be **evidence-grounded**, anchored in *her personal history*.

This includes making use of:
- Movement disorder patterns already documented,
- Her prior sensitivity to dopamine-blocking agents,
- Her metabolic profile (HbA1c, lipids),
- Thyroid data,
- Medication-response patterns,
- Behavioural trajectories.

### **3. Tone**
- Medical-grade accuracy,
- But in language a **non-medical family member can understand**.

### **4. Format**
- **Narrative**, not side-by-side tables.
- Cover each plan one at a time:
  1. **Paliperidone 50 mg + Olanzapine 10 mg**
  2. **Clozapine start + Olanzapine 10 mg taper-off**

### **5. Persona**
You already have a predefined persona; I will insert a placeholder.

### **6. Context sources**
GPT-5 must be instructed to actively use the content from **all three documents**, which you provided:

- **Suparna Goyal Case File** fileciteturn0file0
- **Hypothesis Doc** fileciteturn0file1
- **Test Results (Labs)** fileciteturn0file2

I will embed all three references into the final prompt.

---

# ‚úÖ **What I Can Already Infer from the Documents**

Based on the combined files, the model will already understand:

### ‚ñ† **She is extremely EPS-sensitive**, especially to:
- Risperidone
- Paliperidone (oral or LAI)
‚Üí Both caused **whole-body tremors**, ‚Äústress-sensitive coarse tremor,‚Äù worsening after injections, and partial relief during washout.
‚Üí Very low likelihood these tremors are classic Parkinsonism or akathisia (confirmed in your Hypothesis doc) fileciteturn0file1.

### ‚ñ† **She is partially treatment-resistant**
She relapsed *even on 100 mg paliperidone LAI*, and functioned best only during **paliperidone + olanzapine combination** periods.
‚Üí This supports clozapine evaluation.

### ‚ñ† **Her labs show‚Ä¶**
- Borderline dysglycemia (HbA1c 6.3 ‚Üí now 6.0) fileciteturn0file2
- Slightly low HDL and moderate dyslipidemia
- Normal kidney/liver function
- No neutropenia
- History of elevated TSH ‚Üí corrected
‚Üí Important for clozapine metabolic forecasts.

### ‚ñ† **Her functional deterioration patterns are tightly linked to medication stability**, e.g.:
- Olanzapine reinstatement ‚Üí rapid rescue
- Olanzapine dose drops ‚Üí relapse
- Non-adherence ‚Üí catastrophic fasting/aggression phases
- Paliperidone ‚Üí good symptom control but intolerable movement disorder
‚Üí This extremely rich pattern allows GPT-5 to forecast with unusually high precision.

---

# ‚ùì **Final Clarifying Questions Before I Build Your Master Prompt**

I want to ensure the final prompt is *perfect* for GPT-5 Pro.

### **1Ô∏è‚É£ For the clozapine scenario:**
Do you want GPT-5 to:
- A) Forecast side effects *only for clozapine + initial olanzapine 10 mg*,
OR
- B) Also forecast the **later stage when olanzapine is removed**?

I can structure it either way.

---

### **2Ô∏è‚É£ Do you want the model to explicitly discuss *serious but rare* clozapine risks?**
Examples:
- Myocarditis
- Agranulocytosis
- Seizures
- Ileus/constipation

Or should the model:
- Only list **statistically likely** side effects?

---

### **3Ô∏è‚É£ For improvements (not the main focus but still required):**
Should GPT-5:
- Focus narrowly on *psychotic symptom improvement*?
(e.g., paranoia, food delusions, coercive control, isolation)
OR
- Also consider *functional improvements*?
(e.g., nutrition, movement stability, social engagement)

---

### **4Ô∏è‚É£ Should the prompt instruct GPT-5 to quantify likelihoods?**
Examples:
- ‚ÄúHigh / medium / low probability‚Äù
- ‚ÄúExpected in X% of patients‚Äù
- Or free-form narrative probability language?

---

### **5Ô∏è‚É£ Output structure**
Would you like:

A. **Strict structure** (same headings for each drug plan):
- Expected side effects at week 1 / week 3 / week 12
- Expected improvements at week 1 / week 3 / week 12
- Mechanisms
- Risks based on her personal history
- Monitoring markers

OR

B. **More flexible narrative** (loose paragraphs, not strictly boxed)?

---

Once you answer these, I will **begin building your final GPT-5 Pro prompt**. It will be extremely structured, evidence-grounded, include the persona placeholder, reference all three files for context, and produce a deeply thorough forecast for each treatment plan.

Ready when you are.

## You (2025-11-22T19:23:39.601000+00:00)

1. for clozapine, i want chatGPT to forecast the side effects of clozapine + initial olanzapine 10mg; and an olanzapine 5mg + clozapine; and then clozapine only.
2. I want it to briefly discuss these serious cases, but primary focus should be the most probably side effects based on all the patient's history, medical information, and similar patients it can find through literature and thorough research.
3. focus narrowly on psychotic symptom improvement.
4. yes.
5. more flexible narrative but ones that cover the structure i need.

---
begin creating the prompt.

## ChatGPT (2025-11-22T19:23:40.867005+00:00)

Below is your **fully constructed master prompt** for GPT-5 Pro mode.

It integrates:
‚Ä¢ Your predefined psychiatrist persona (left as a placeholder)
‚Ä¢ All three attached documents as context sources
‚Ä¢ The narrative structure you asked for
‚Ä¢ Forecasts across 1 / 3 / 12 weeks
‚Ä¢ Probability-weighted predictions
‚Ä¢ Focus on psychotic symptom improvement
‚Ä¢ Side-effect forecasts for **both plans**, including:
‚ÄÉ‚Äì paliperidone 50 mg + olanzapine 10 mg
‚ÄÉ‚Äì clozapine + olanzapine 10 mg
‚ÄÉ‚Äì clozapine + olanzapine 5 mg
‚ÄÉ‚Äì clozapine monotherapy
‚Ä¢ Explicit incorporation of her medication sensitivities, EPS history, metabolic profile, relapse patterns, and movement disorder characteristics
‚Ä¢ Use of all attached files via citation tokens
‚ÄÉ(Suparna Goyal case file: fileciteturn0file0
‚ÄÉHypothesis doc: fileciteturn0file1
‚ÄÉTest results: fileciteturn0file2)

You can paste it directly into GPT-5 Pro.

---

# ‚úÖ **FINAL PROMPT FOR GPT-5 PRO MODE**

**[INSERT PERSONA HERE]**

You are working with the complete clinical history, hypotheses, and lab data contained in the following three documents. Use them as your primary evidence base and cite them as needed:

- **Suparna Goyal Case File**: fileciteturn0file0
- **Hypothesis Document**: fileciteturn0file1
- **Test Results & Lab Panels**: fileciteturn0file2

Your task is to provide a **thorough, medically serious, probability-weighted forecast** comparing two treatment strategies for a 60-year-old woman with a chronic psychotic disorder that has shown **extreme medication sensitivity**, **significant relapses tied to antipsychotic reductions**, and **severe medication-induced movement disorders**, especially with risperidone and paliperidone.

The two treatment plans to evaluate:

---

## **PLAN A ‚Äî Paliperidone 50 mg + Olanzapine 10 mg**

Forecast the **most likely side effects** and **expected improvements**, organized into three time horizons:

- **1 week**
- **3 weeks**
- **12 weeks**

Focus particularly on:

1. **Side-effect risks grounded in her personal history**, including:
   - Coarse, whole-body medication-induced tremors
   - Sensitivity to dopamine blockade
   - History of relapse when olanzapine is reduced
   - Stress-linked movement patterns
   - Prior worsening with paliperidone injections
   - Metabolic and endocrine risks per HbA1c, lipids, thyroid data
   - Past cycles of food refusal, aggression, and coercive control

2. Provide clear **probability-weighted language** (e.g., ‚Äúhighly likely (~70%+)‚Äù, ‚Äúmoderate probability‚Äù, ‚Äúlow probability but important to monitor‚Äù).

3. Forecast **expected psychotic improvements only**, not functional or social improvements.
   Improvements should be described narrowly in terms of:
   - Reduction in paranoia
   - Reduction in food-related delusions
   - Reduction in coercive control behavior
   - Reduced relapse risk and stabilization patterns

4. Use a **flexible narrative style**, but ensure all the above elements are included.

---

## **PLAN B ‚Äî Clozapine-Based Strategy**

Forecast side effects and improvements for three phases:

### **Phase 1: Clozapine initiation + Olanzapine 10 mg**
### **Phase 2: Clozapine + Olanzapine 5 mg**
### **Phase 3: Clozapine monotherapy**

For each of the three phases, provide:

- **Most likely side effects** at 1 week, 3 weeks, and 12 weeks, with probability-weighted phrasing.
- **Expected psychotic improvements**, narrowly defined as above.
- Commentary on how her personal patterns (EPS sensitivity, relapse history, delusional cycles, metabolic status) interact with clozapine‚Äôs known profile.

### Briefly cover the following **serious but less common clozapine risks**:

- agranulocytosis
- myocarditis
- seizures
- ileus / severe constipation
- profound sedation / sialorrhea

Discuss them **briefly** and describe whether her personal history or lab profile makes these risks more or less probable than average.

### Focus mainly on:
- The **most likely and most predictable** side effects based on:
  - her detailed medication responses
  - the documented tremor phenomenology
  - her endocrine/metabolic panels
  - literature-based expectations for similar patients

---

# **General Instructions for Reasoning**

1. **Ground every forecast in data** from the three documents‚Äîher observed patterns, relapse timing, tremor characteristics, metabolic data, thyroid function, and the longitudinal trajectories described.
2. Avoid guesswork: anchor predictions in a combination of **her personal case pattern**, **clinical pharmacology**, and **population-level evidence**.
3. When uncertain, state uncertainty explicitly.
4. Do not provide treatment advice or mitigation strategies; the task is **forecasting only**.
5. Maintain a **medical explanation level** but in language accessible to a non-medical family member.

---

# **Output Format**

Use a flexible narrative style, but ensure your output contains:

- A clear **section for Plan A**
- Three clear **sections for the three Clozapine Plan B phases**
- Under each section:
  - **Side-effect forecast (1 / 3 / 12 weeks)**
  - **Expected psychotic improvement (1 / 3 / 12 weeks)**
  - **Probability indicators**
  - **Mechanistic explanation where useful**
  - **Explicit reference to her personal medication response history**

You may structure paragraphs freely as long as all elements are included.

---

# **Begin your evaluation now.**

---

If you want any adjustments (more technical, more concise, more rigid structure), I can revise it.

## You (2025-11-22T19:26:19.550000+00:00)

in the 'General Instructions for Reasoning' section, should we ask it to actually go out and look for data through multiple literature studies and published research? I want to make sure the data is grounded in research and I want to make sure it does a thorough research.

## ChatGPT (2025-11-22T19:26:21.148993+00:00)

Here is the exact improvement you‚Äôre aiming for ‚Äî **yes**, you *can and should* instruct GPT-5 Pro Mode to perform **active literature search**, cite studies, compare findings, and triangulate with her case history.

But it must be done without violating GPT-5‚Äôs rules (e.g., avoiding fabricated citations). The correct way is to instruct it to **perform a multi-source literature sweep**, summarize evidence, and name *study authors / journals / years only when verified*, while avoiding fake DOIs or page numbers.

Below is the **perfectly worded upgrade** to the ‚ÄúGeneral Instructions for Reasoning‚Äù section.

You can paste this **directly** into the prompt, replacing the previous version of that section.

---

# ‚úÖ **Revised ‚ÄúGeneral Instructions for Reasoning‚Äù (includes literature research)**

**General Instructions for Reasoning**

1. **Actively conduct a broad literature review** using your internal knowledge and retrieval capabilities.
   Your evaluation must integrate findings from:
   - large meta-analyses
   - comparative effectiveness trials
   - long-term outcome studies
   - pharmacovigilance reports
   - clozapine and paliperidone side-effect prevalence data
   - movement disorder literature (tremor vs EPS vs tardive patterns)
   - metabolic and endocrine risk studies for antipsychotics

2. You must **cross-validate** every major claim using at least **two** independent evidence sources whenever possible, unless it concerns a well-established pharmacologic mechanism.

3. When referencing research, you may name:
   - study authors
   - journal names
   - publication year
   - large cohort names
   - trial acronyms
   BUT **do not generate DOIs, volume numbers, or page numbers.**
   If uncertain about a detail, state so explicitly.

4. Integrate all literature findings with the patient‚Äôs personal data from:
   - **Suparna Goyal Case File** fileciteturn0file0
   - **Hypothesis Document** fileciteturn0file1
   - **Test Results** fileciteturn0file2
   Specifically reference her:
   - severe EPS sensitivity
   - tremor subtype
   - relapse patterns
   - metabolic state (HbA1c, lipids, weight risk)
   - thyroid history
   - dose‚Äìresponse behaviour with olanzapine, risperidone, paliperidone
   - rapid deterioration off antipsychotics
   - periods of partial stabilization

5. Avoid guesswork. When evidence is limited or contradictory, state:
   - what is known
   - what remains uncertain
   - what is speculative, and why

6. Keep the tone **highly analytic but understandable to a non-medical family member**, without diluting clinical accuracy.

---

# If you want, I can now:
‚úÖ Insert this revised version **directly** into the full master prompt,
or
‚úÖ Re-generate the entire prompt with this integrated cleanly.

Just tell me **‚Äúregenerate the final prompt with this included‚Äù** and I will rebuild the entire thing perfectly.

## You (2025-11-22T19:28:32.526000+00:00)

regenerate the final prompt with this and the given persona included

## ChatGPT (2025-11-22T19:28:33.731947+00:00)

Below is your **fully regenerated, final, production-ready GPT-5 Pro Mode prompt** ‚Äî now including:

‚úî Your full psychiatrist persona (embedded)
‚úî The upgraded *General Instructions for Reasoning* with literature review requirements
‚úî Explicit references to all three patient documents
‚úî Correct formatting, structure, and the flexible narrative expectations
‚úî All forecasting requirements for both treatment plans
‚úî Probability-weighted expectations
‚úî Week-by-week horizon (1 / 3 / 12 weeks)
‚úî Clozapine 3-stage structure
‚úî No missing elements

You can paste this directly into GPT-5 Pro Mode.

---

# ‚úÖ **FINAL GPT-5 PRO MODE PROMPT (FULLY REGENERATED)**

**ROLE / PERSONA (USE FOR EXECUTION)**
You are a seasoned psychiatrist, ten years or so beyond your training, shaped by long work with stubborn illnesses‚Äîschizophrenia, schizoaffective disorder, and the harsher moods of bipolarity. Clozapine and depot paliperidone are familiar companions, not rare trials. You have started clozapine often enough to know its whole temperament: the strong recoveries, the slow partial gains, and the early stoppages from sedation, constipation, myocarditis, neutropenia, or seizures. With paliperidone you know the lay of the land‚Äîprolactin changes, stiffness, restlessness, weight and glucose drifting, and how these shift when olanzapine stands beside it.

You think with one eye on the mind and the other on the body. Diabetes, obesity, heart strain, bowel slowing, frail blood counts‚Äîyou have managed them all while guiding antipsychotic care. You take a careful medication history, draw clean timelines, judge risks before you act, and follow weight, vitals, labs, and symptoms with fixed regularity. You prepare early-warning plans and avoid needless complexity, trimming old medicines that no longer earn their keep.

You speak plainly, share your reasoning, and respect the patient‚Äôs fears and limits. You rely on steady systems‚Äîlabs, monitors, colleagues‚Äîknowing that safe care is always a team‚Äôs work, never a lone effort.

---

# üìò **Context Sources (Mandatory)**
Use all information from the following three documents:

1. **Suparna Goyal Case File**
   *(local path: /mnt/data/Suparna Goyal 1bb255400f3f805cba40fc333d487275.md)*
   Token: fileciteturn0file0

2. **Hypothesis Document**
   *(local path: /mnt/data/Hypothesis doc 2b3255400f3f8069a08ac31879e07959.md)*
   Token: fileciteturn0file1

3. **Test Results & Lab Panels**
   *(local path: /mnt/data/Test Results 2b3255400f3f809ab624f078fbafd8b8.md)*
   Token: fileciteturn0file2

Your entire evaluation **must be grounded** in these documents **plus** your literature research (see instructions below).

---

# üîç **General Instructions for Reasoning (Revised)**

1. **Actively conduct a broad literature review** using your internal knowledge and retrieval capabilities.
   Integrate findings from:
   - meta-analyses
   - long-term outcome studies
   - pharmacovigilance data
   - antipsychotic side-effect prevalence research
   - movement disorder literature (tremor, EPS, tardive patterns)
   - clozapine initiation cohorts
   - paliperidone vs clozapine comparative studies

2. For every major clinical claim, **cross-validate using at least two independent evidence sources**, unless it concerns a universally established pharmacologic fact.

3. When referencing research, you may include:
   - study authors
   - publication year
   - journal names
   - well-known trial acronyms (CATIE, CUtLASS, TEOSS, etc.)
   **Do NOT generate DOIs, page numbers, or unverifiable citation details.**
   If uncertain, state uncertainty explicitly.

4. Integrate all literature findings with the patient‚Äôs personal data from the three documents (case file, hypothesis doc, and labs). Give specific weight to:
   - severe EPS sensitivity and coarse whole-body tremor patterns
   - stress-linked tremor worsening
   - relapse patterns tied to olanzapine reduction
   - response patterns to paliperidone and risperidone
   - metabolic risks per HbA1c, fasting glucose, HDL/LDL profile
   - thyroid history
   - consistent partial improvement on olanzapine
   - relapse even while on paliperidone LAI 100 mg
   - evidence of treatment resistance

5. Avoid guesswork.
   Clearly mark anything that is:
   - well-supported
   - moderately supported
   - uncertain
   - speculative (and why)

6. Maintain a tone that is **clinically precise but understandable to a non-medical family member**.

7. **Do not give treatment recommendations.**
   Your task is **forecasting only**.

---

# üß≠ **Your Task**

Provide a **comprehensive, narrative, probability-weighted** forecast of side-effects and psychotic improvements for the following two major treatment strategies:

---

# **PLAN A ‚Äî Paliperidone 50 mg + Olanzapine 10 mg**

For this combined regimen, forecast:

### 1. **Most likely side effects** at:
- **1 week**
- **3 weeks**
- **12 weeks**

Prioritize side effects that are **highly predictable** from:
- Her documented EPS sensitivity (including tremor phenomenology)
- Her history of paliperidone-induced movement disorder (coarse, stress-sensitive tremor, worsened with injections)
- Prior patterns of worsening with LAI paliperidone
- Her metabolic profile (HbA1c 6.3 ‚Üí 6.0, low HDL)
- Thyroid fluctuations
- Past behavioral destabilization when olanzapine dose was reduced

Use **probability language** (e.g., ‚Äúhighly likely,‚Äù ‚Äúmoderate probability,‚Äù ‚Äúlow but important‚Äù).

### 2. **Expected psychotic symptom improvements** at:
- 1 week
- 3 weeks
- 12 weeks

Focus *narrowly* on:
- paranoia reduction
- food-related delusions
- coercive control
- relapse risk

Do **not** discuss social function, motivation, or daily activity unless directly linked to psychotic symptom change.

Provide a **flexible narrative**, not bullet points, but ensure all components are included.

---

# **PLAN B ‚Äî Clozapine-Based Strategy (Three Phases)**

You must evaluate these **three sequential phases**:

### **Phase 1:** Clozapine initiation + Olanzapine 10 mg
### **Phase 2:** Clozapine + Olanzapine 5 mg
### **Phase 3:** Clozapine monotherapy

For **each phase**, provide:

### 1. **Side-effect forecasts** at:
- 1 week
- 3 weeks
- 12 weeks

Use probability-weighted language.

Include side-effect predictions most relevant to her profile, including how clozapine interacts with:
- her metabolic vulnerabilities
- prior tremor and EPS patterns
- relapse history
- thyroid and glucose history
- previous anticholinergic burden
- sensitivity to dopamine blockade

### 2. **Expected psychotic symptom improvements** at:
- 1 week
- 3 weeks
- 12 weeks

Focus solely on psychosis (paranoia, delusions, coercive control, relapse patterns).

### 3. **Brief but accurate discussion** of serious but uncommon clozapine risks:
- agranulocytosis
- myocarditis
- seizures
- ileus/severe constipation
- profound sedation/sialorrhea

Describe whether her personal profile increases, decreases, or does not affect these risks ‚Äî based on evidence from:
- literature
- pharmacology
- her lab values
- her historical medication tolerability

Do **not** spend more than a brief section on rare risks; keep focus on *most likely* outcomes.

---

# üéØ **Output Requirements**

Your output must contain:

- A **Plan A** narrative section
- A **Plan B Phase 1** narrative section
- A **Plan B Phase 2** narrative section
- A **Plan B Phase 3** narrative section

Each must include:
- Probability-weighted **side-effect forecasts** (1 / 3 / 12 weeks)
- Probability-weighted **psychotic improvement forecasts** (1 / 3 / 12 weeks)
- Integration of literature + her personal patterns + lab data
- Clear mechanistic explanations where useful
- No bullet points unless they serve clarity; narrative is preferred

End with **no recommendations**‚Äîonly forecasts.

---

# **Begin your thorough, literature-informed, probability-weighted evaluation now.**

---

If you‚Äôd like, I can also create a short version, an ultra-structured version, or a more conversational version.
